Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
From the Editors
Nature Reviews Cancer 8, 565 (1 August 2008) | doi:10.1038/nrc2457
From the editors
Abstract
In his seminal 1971 New England Journal of Medicine paper M. Judah Folkman wrote, “The mechanism by which tumour implants stimulate neovascularization must be well understood before therapy based on interference with angiogenesis can be devised.” Although research on angiogenesis was well-founded by this time, its potential therapeutic value for treating patients with cancer had not been voiced.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
